Positive Outcomes for People who use Poppers Research Study (POPPRS)

The Positive Outcomes for People who use Poppers Research Study (POPPRS) explores who uses poppers and why, health outcomes related to poppers use, and other factors that may influence poppers use experiences. Through this study, we hope to inform regulation and public health strategies that will reduce harm from poppers use and result in better health outcomes for people who use poppers.

The study has three main components: 

  • Interviews with people who use poppers during sex 
  • Interviews with people who have professional experience related to poppers  

 

We are currently recruiting people who use poppers. To be eligible to participate in an interview, you must: 

  • Be at least 15 years old 
  • Live in Canada 
  • Avoir consommé des poppers dans le cadre de rapports sexuels au cours des 3 derniers mois (ou avoir ressenti des effets secondaires importants au cours des 12 derniers mois) 

Have used poppers during sex in the last 3 months OR in the last 12 months if you have experienced significant side effects 

Your input will help identify opportunities to improve the lives of people who use poppers. 

+ 1 (514) 617-1705 (text or call) 

Cameron Schwartz, research coordinator. University of British Columbia

Psilocybin and Mental Health

The study “Psilocybin and Mental Health” focuses on the use of psilocybin (magic mushrooms) in Canada among youth aged 15 to 24 in the context of increasing conditions of accessibility of psilocybin-based products on the market. It aims specifically to understand the motivations of adolescents and young adults, the contextual factors of consumption, and experiences associated with mental health. 

Rodney Knight, principal investigator. CR CHUM

Context study

FOCUS is an international study on the well-being of young people under 30 living in France and Canada in the context of the pandemic. Our goal is to highlight young people’s perspectives through research to help shape social, economic, and health policies. Together, we can make our voices heard!

Pierre-julien Coulaud, post-doctoral fellow at CERPOP
Université de Toulouse III Paul Sabatier

Main results from the first survey

Hepco Pain

Understanding how chronic pain influences illicit substance use and the risk of harm among people who inject drugs.

Jennifer Cohen Reyes, étudiante au Doctorat en Santé publique, CRCHUM

People who inject drugs (PWID) are a highly marginalized group, exposed to Canada’s synergistic opioid, overdose, and infectious disease crises, with global mortality rates approximately 15 times higher than the general population. Estimates suggest that about 50% of these individuals live with chronic pain (intermittent or continuous pain lasting more than 3 months), a condition associated with significant functional impairment and mental distress. However, we know very little about their chronic pain experience, including links to substance use and adverse events, knowing that PWID are vulnerable to inadequate pain care. Examining these relationships and building an evidence base to guide tailored interventions is a critical frontier in protecting the health of PWID with chronic pain.

This study will generate essential insights for developing appropriate strategies to manage chronic pain and its consequences among PWID, ultimately contributing to the creation of data-driven models of care and guidelines that better address pain in the context of ongoing substance use.

Implementation Science Team Grant (IS Team Grant)

This study examines the co-occurring rates of HIV and other sexually transmitted and blood-borne infections (STBBIs) and substance use among young Two-Spirit, lesbian, gay, bisexual, transgender, queer, intersex and other youth (2SLGBTQI+) youth through a lens of implementation science. Through the intensive study of interventions from within the clinical and policy domains, this study aims to inform the adaptation and scale-up of key interventions. Interventions that concurrently address substance use and sexual harms (e.g., STBBIs, HIV-related outcomes) and other known co-morbidities (e.g., psychiatric comorbidities) are of particular interest.

Anna Carson, Research Coordinator 

Partners 

Objectives

Sexual and Gender Minority Youth & Cannabis Use

Identifying the impact of cannabis use on mental health outcomes among sexual and gender minority youth: A mixed methods study

 Caroline Mniszak, Research coordinator

This study explores how young Sexual and Gender Minority (SGM) youths’ experiences with cannabis and mental health challenges influence their lives. We are also interested in understanding how the COVID-19 pandemic has impacted youth experiences. By participating in this photovoice project and interview, you will have the opportunity to tell your story and help us improve the provision of substance use and mental health policy, programming, and prevention strategies for Sexual and Gender Minority youth in BC.